C4 Therapeutics Inc (CCCC)
1.5400 x 10 1.6400 x 2
Pre-market by (Cboe BZX)
1.5400 -0.0700 (-4.35%) 04/25/25 [NASDAQ]
1.5400 x 10 1.6400 x 2
Pre-market 1.5500 +0.0100 (+0.65%) 04:40 ET
for Fri, Apr 25th, 2025
Results
download Want to compare other data? Select FieldsSymbol | CCCC | IMUX | COYA | ||
Company | C4 Therapeutics Inc | Immunic Inc | Coya Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.6000 | 1.1700 | 6.17 | ||
High | 1.6361 | 1.2199 | 6.58 | ||
Low | 1.4900 | 1.0950 | 6.04 | ||
Last | 1.5400 | 1.1100 | 6.18 | ||
Change | -0.0700 | -0.0300 | -0.35 | ||
% Change | -4.35% | -2.63% | -5.36% | ||
Volume | 1,278,300 | 423,700 | 43,300 | ||
20-Day Average Volume | 1,343,445 | 661,560 | 85,415 | ||
Previous Close | 1.6100 | 1.1400 | 6.53 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 1.3885 | 1.0108 | 5.81 | ||
20-Day Raw Stochastic | 58.40% | 62.06% | 63.49% | ||
20-Day Relative Strength | 41.65% | 53.70% | 51.16% | ||
Weighted Alpha | -77.59 | -22.29 | -22.31 | ||
Today's Opinion | 88% Sell | 32% Sell | 48% Sell | ||
Previous Opinion | 88% Sell | 32% Sell | Hold | ||
Last Month's Opinion | 100% Sell | 8% Sell | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +23.20% since 04/17/25 | +13.27% since 04/17/25 | +17.49% since 04/17/25 | ||
Low | 1.2001 on 04/21/25 | 0.9600 on 04/21/25 | 5.06 on 04/21/25 | ||
High | 1.7400 on 04/23/25 | 1.2199 on 04/25/25 | 7.05 on 04/23/25 | ||
1-Month | |||||
%Chg | -29.36% since 03/25/25 | -11.20% since 03/25/25 | -5.65% since 03/25/25 | ||
Low | 1.0900 on 04/17/25 | 0.8319 on 04/09/25 | 4.65 on 04/09/25 | ||
High | 2.1600 on 03/26/25 | 1.2800 on 03/28/25 | 7.06 on 03/28/25 | ||
3-Month | |||||
%Chg | -57.58% since 01/24/25 | +8.82% since 01/24/25 | +4.75% since 01/24/25 | ||
Low | 1.0900 on 04/17/25 | 0.8319 on 04/09/25 | 4.65 on 04/09/25 | ||
High | 3.8400 on 01/31/25 | 1.3900 on 02/21/25 | 8.29 on 03/03/25 | ||
6-Month | |||||
%Chg | -73.85% since 10/25/24 | -20.14% since 10/25/24 | -31.03% since 10/25/24 | ||
Low | 1.0900 on 04/17/25 | 0.8319 on 04/09/25 | 4.65 on 04/09/25 | ||
High | 6.5200 on 11/04/24 | 1.4200 on 12/02/24 | 10.24 on 10/28/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 93,019 | 95,339 | 91,151 | ||
Shares Outstanding, K | 71,007 | 95,818 | 16,725 | ||
Annual Sales | 35,580,000 | 0 | 3,550,000 | ||
Annual Net Income | -105,320,000 | -100,510,000 | -14,880,000 | ||
Last Quarter Sales | 5,180,000 | 0 | 0 | ||
Last Quarter Net Income | -34,570,000 | -25,180,000 | -4,020,000 | ||
60-Month Beta | 3.11 | 1.91 | 0.49 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.49 on 02/27/25 | -0.24 on 11/07/24 | -0.18 on 03/18/25 | ||
Latest Earnings Date | 05/14/25 | 05/14/25 | 05/08/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |